Author/Creator: de Azambuja, E - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator de Azambuja, E

1. 90OThe role of dose-dense (DD) adjuvant chemotherapy (CT) in HER2-positive (HER2+) early breast cancer (BC) patients (pts) before and after the introduction of trastuzumab (T): Exploratory analysis of the GIM2 trial. (13th May 2019)

Authors:: Lambertini, M; Bruzzone, M; Poggio, F; Conte, B; de Azambuja, E; Bisagni, G; De Laurentiis, M; de Placido, S; Cognetti, F; Del Mastro, L
Journal:: Annals of oncology
Issue:: Volume 30(2019)Supplement 3
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 76PPrognostic and predictive significance of the expression of the beta-2 adrenergic receptor in HER2-positive breast cancer. (13th May 2019)

Authors:: Richard, F; Bitton, R C; Sotiriou, C; de Azambuja, E
Journal:: Annals of oncology
Issue:: Volume 30(2019)Supplement 3
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients. (10th October 2017)

Authors:: Lambertini, M; Goldrat, O; Ferreira, A R; Dechene, J; Azim Jr, H A; Desir, J; Delbaere, A; t'Kint de Roodenbeke, M -D; de Azambuja, E; Ignatiadis, M; Demeestere, I
Journal:: Annals of oncology
Issue:: Volume 29:Number 1(2018)
Page Start:: 237
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. 218PAutoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial. (23rd October 2018)

Authors:: Sonnenblick, A; Bailey, A; Uziely, B; Untch, M; Smith, I; Gianni, L; Baselga, J; Jackisch, C; Cameron, D; Bell, R; Zardavas, D; Al-Sakaff, N; Gelber, R; Dowsett, M; Leyland-jones, B; Piccart, M; de Azambuja, E
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. 247PShould anthracyclines always be present in the adjuvant treatment of breast cancer (BC)? A systematic review and meta-analysis of randomized controlled trials (RCTs). (23rd October 2018)

Authors:: Caparica, R; Bruzzone, M; Poggio, F; Ceppi, M; de Azambuja, E; Lambertini, M
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Impact of ARTs on oncological outcomes in young breast cancer survivors. Issue 2 (8th December 2020)

Authors:: Condorelli, M; De Vos, M; Lie Fong, S; Autin, C; Delvigne, A; Vanden Meerschaut, F; Wyns, C; Imbert, R; Cheruy, C; Bouziotis, J; de Azambuja, E; Delbaere, A; Lambertini, M; Demeestere, I
Journal:: Human reproduction
Issue:: Volume 36:Issue 2(2021)
Page Start:: 381
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trial. (26th June 2019)

Authors:: Holmes, E M; Bradbury, I; Williams, L S; Korde, L; de Azambuja, E; Fumagalli, D; Moreno-Aspitia, A; Baselga, J; Piccart-Gebhart, M; Dueck, A C; Gelber, R D
Journal:: Annals of oncology
Issue:: Volume 30:Number 9(2019)
Page Start:: 1507
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗